Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Dividends
  • Earnings
  • Equities
  • Guidance
  • Markets
  • News

Honeywell Gains After Solid Q1 Results And Raised FY23 Guidance

By Akanksha Bakshi
April 27, 10:02 AM
Honeywell International Inc (NASDAQ:HON) reported first-quarter FY23 sales of $8.86 billion, up 6% Y/Y on a reported basis and 8% on…

HON

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Why AbbVie Shares Are Trading Lower Today

By Vandana Singh
April 27, 9:58 AM
AbbVie Inc (NYSE: ABBV) has reported Q1 adjusted EPS of $2.46</

ABBV

Read More
1 minute read
  • Biotech
  • Earnings
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Why Eli Lilly Shares Are Trading Higher Today

By Vandana Singh
April 27, 9:55 AM
Eli Lilly And Co (NYSE: LLY) has reported 

LLY

Read More
2 minute read
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

Mastercard Q1 Earnings Exceed Expectations On Strong Key Metrics

By Lekha Gupta
April 27, 9:42 AM
Mastercard Inc (NYSE:MA) reported Q1 2023 net revenues of $5.75 billion, up 11% Y/Y and 14% on neutral currency…

MA

Read More
1 minute read
  • Earnings
  • Earnings Beats
  • Equities
  • Guidance
  • Markets
  • News

A O Smith Q1 Earnings Beats On Resilient Water Heater Demand, Raises FY23 EPS Guidance

By Nabaparna Bhattacharya
April 27, 9:08 AM
A.O. Smith Corp (NYSE:AOS) first-quarter FY23 sales inched down by 1% year-over-year to $966.4 million, beating the consensus of $922.26 million.…

AOS

Read More
2 minute read
  • Earnings
  • Guidance
  • News

Appreciate Announces Preliminary Results For Q1 Ended March 31, 2023; Sees Q1 Revenue $6.7M; Preliminary Unrestricted Cash & Cash Equivalents As Of March 31, 2023 ~$0.2M

By Happy Mohamed
April 27, 8:36 AM
Q1 2023 Preliminary Unaudited Financial Results Preliminary total revenue for the quarter was approximately $6.7 million, a decline of 3.7% compared to the first quarter of 2022. The

SFR

Read More
1 minute read
  • Guidance
  • News

Grainger Updates FY23 Outlook, Sees Net Sales Of $16.2B-$16.8B Vs $16.51B Estimate; EPS Of $34.25-$36.75 Vs Estimate $33.37, Prior $32-$34.50

By Benzinga Newsdesk
April 27, 8:11 AM
Given the strong first quarter results and expectations for the remainder of the year, the Company is updating its full year 2023 guidance ranges as noted below, including an

GWW

Read More
1 minute read
  • Guidance
  • News

Medical Properties Trust FY23 FFO Outlook $1.50 – $1.61 Vs. $1.59, EPS $0.06 – $0.07

By Benzinga Newsdesk
April 27, 8:04 AM
(Unaudited)                     2023 Guidance - Per (Unaudited)    

MPW

Read More
1 minute read
  • Guidance
  • News

PROCEPT BioRobotics FY23 Revenue Outlook $128M Vs. $126.11M Estimate

By Benzinga Newsdesk
April 27, 7:21 AM
Full Year 2023 Financial Guidance The Company projects revenue for the full year 2023 to be $128 million, which represents 71% growth over the Company's prior year revenue. This compares to previous revenue

PRCT

Read More
1 minute read
  • Guidance
  • News

Opera Q2 Revenue Outlook $92M – $94M Vs. $90.27M

By Benzinga Newsdesk
April 27, 7:18 AM
Business Outlook “I am very pleased with the opening trajectory of 2023 and while it is only two months since we last spoke, we are cautiously raising the lower-end of our revenue guidance and both ends of our

OPRA

Posts pagination

Previous 1 … 442 443 444 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service